1. Home
  2. ANIX vs AKA Comparison

ANIX vs AKA Comparison

Compare ANIX & AKA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Anixa Biosciences Inc.

ANIX

Anixa Biosciences Inc.

HOLD

Current Price

$2.97

Market Cap

102.6M

Sector

Health Care

ML Signal

HOLD

Logo a.k.a. Brands Holding Corp.

AKA

a.k.a. Brands Holding Corp.

N/A

Current Price

$11.38

Market Cap

113.4M

ML Signal

N/A

Company Overview

Basic Information
Metric
ANIX
AKA
Founded
1982
2018
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Catalog/Specialty Distribution
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
102.6M
113.4M
IPO Year
2013
2021

Fundamental Metrics

Financial Performance
Metric
ANIX
AKA
Price
$2.97
$11.38
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
3
3
Target Price
$8.67
$24.33
AVG Volume (30 Days)
113.0K
3.0K
Earning Date
05-27-2026
05-12-2026
Dividend Yield
N/A
N/A
EPS Growth
12.82
N/A
EPS
N/A
N/A
Revenue
$210,000.00
$600,208,000.00
Revenue This Year
N/A
$6.14
Revenue Next Year
N/A
$4.89
P/E Ratio
N/A
N/A
Revenue Growth
N/A
4.44
52 Week Low
$2.44
$8.60
52 Week High
$5.46
$16.38

Technical Indicators

Market Signals
Indicator
ANIX
AKA
Relative Strength Index (RSI) 51.78 63.07
Support Level $2.74 $10.51
Resistance Level $3.11 $11.75
Average True Range (ATR) 0.18 0.59
MACD -0.01 0.05
Stochastic Oscillator 36.88 86.35

Price Performance

Historical Comparison
ANIX
AKA

About ANIX Anixa Biosciences Inc.

Anixa Biosciences Inc is a biotechnology company developing therapies and vaccines focused on critical unmet needs in oncology. Its operations are organized into reportable segments comprising Cancer Vaccines, CAR-T Therapies, and Other. The Cancer Vaccines segment involves vaccines to treat and prevent breast and ovarian cancer, as well as additional cancer vaccines targeting intractable cancers, including high-incidence malignancies in lung, colon, and prostate. The CAR-T Therapies segment involves the development of liraltagene autoleucel (lira-cel), an ovarian cancer immunotherapy using chimeric endocrine receptor-T cell technology, developed at its subsidiary, Certainty Therapeutics, Inc. The Other segment consists of legacy operations, including limited patent licensing activities.

About AKA a.k.a. Brands Holding Corp.

a.k.a. Brands Holding Corp is a portfolio of fashion brands, including Princess Polly, Culture Kings, Petal & Pup, and mnml. Through these brands, the company reaches next-generation consumers who seek fashion inspiration on social media and mainly shop online. The portfolio consists of two women's brands, Princess Polly and Petal & Pup, and two streetwear brands, Culture Kings and mnml. The company generates the majority of its revenue from the United States.

Share on Social Networks: